| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Chanda Sanjay | Chief Development Officer | C/O AN2 THERAPEUTICS, INC., 1300 EL CAMINO REAL, SUITE 100, MENLO PARK | /s/ Lucy Day, Attorney-in-Fact for Sanjay Chanda | 07 Jan 2026 | 0001571820 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANTX | Common Stock | Sale | $3,305 | -3,295 | -3.9% | $1.00 | 81,779 | 05 Jan 2026 | Direct | F1, F2, F3 |
| transaction | ANTX | Common Stock | Sale | $6,027 | -5,956 | -7.3% | $1.01 | 75,823 | 06 Jan 2026 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2026. |
| F2 | Includes (a) 27,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024 and (b) 50,250 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2025, in each case subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date. |
| F3 | Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's Employee Stock Purchase Plan on September 30, 2025. |